Next Article in Journal
Burkholderia cepacia Complex Vaccines: Where Do We Go from here?
Previous Article in Journal
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
Previous Article in Special Issue
Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery
Article Menu

Export Article

Open AccessEditorial
Vaccines 2016, 4(2), 9;

Vaccine Delivery Methods into the Future

Centre for Chronic Disease, College of Health and Biomedicine, Victoria University, Melbourne, VIC 3021, Australia
Academic Editor: Diane M. Harper
Received: 24 March 2016 / Accepted: 25 March 2016 / Published: 28 March 2016
(This article belongs to the Special Issue Vaccine Delivery)
Full-Text   |   PDF [483 KB, uploaded 28 March 2016]   |  


Several modes of vaccine delivery have been developed in the last 25 years, which induce strong immune responses in pre-clinical models and in human clinical trials. Some modes of delivery include, adjuvants (aluminum hydroxide, Ribi formulation, QS21), liposomes, nanoparticles, virus like particles, immunostimulatory complexes (ISCOMs), dendrimers, viral vectors, DNA delivery via gene gun, electroporation or Biojector 2000, cell penetrating peptides, dendritic cell receptor targeting, toll-like receptors, chemokine receptors and bacterial toxins. There is an enormous amount of information and vaccine delivery methods available for guiding vaccine and immunotherapeutics development against diseases. View Full-Text
Keywords: vaccine; vaccine delivery; antigen delivery; immunotherapy vaccine; vaccine delivery; antigen delivery; immunotherapy

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Apostolopoulos, V. Vaccine Delivery Methods into the Future. Vaccines 2016, 4, 9.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top